TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan · Delayed Price · Currency is TWD 7.70
+0.03 (0.39%)
Feb 11, 2026, 2:22 PM CST
TaiwanJ Pharmaceuticals Market Cap
TaiwanJ Pharmaceuticals has a market cap or net worth of 616.94 million as of February 11, 2026. Its market cap has decreased by -3.51% in one year.
Market Cap
616.94M
Enterprise Value
545.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.70
Market Cap Chart
Since October 21, 2015, TaiwanJ Pharmaceuticals's market cap has decreased from 2.26B to 616.94M, a decrease of -72.65%. That is a compound annual growth rate of -11.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 616.94M | -0.13% |
| Dec 31, 2025 | 617.74M | -5.98% |
| Dec 31, 2024 | 657.00M | -40.71% |
| Dec 29, 2023 | 1.11B | 39.15% |
| Dec 30, 2022 | 796.29M | 4.93% |
| Dec 30, 2021 | 758.89M | -24.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 1.20B |
| Holy Stone Healthcare | 1.17B |
| Neith | 1.16B |
| Level Biotechnology | 1.06B |
| TCI GENE | 1.01B |
| Taiwan Advance Bio-Pharmaceutical | 994.50M |
| Eusol Biotech | 993.25M |
| NatureWise Biotech & Medicals | 921.25M |